PELTHOS THERAPEUTICS INC (PTHS) Stock Overview
NYSEARCA:PTHS - US1711262048 - Common Stock
PTHS Key Statistics, Chart & Performance
The current stock price of PTHS is 23.6505 USD. In the past month the price increased by 13.4%.
PTHS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.87 | 371.68B | ||
| AMGN | AMGEN INC | 13.19 | 154.89B | ||
| GILD | GILEAD SCIENCES INC | 14.6 | 140.17B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.08 | 100.25B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.72 | 61.55B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 58.53B | ||
| ARGX | ARGENX SE - ADR | 76.83 | 43.59B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.16 | 36.38B | ||
| INSM | INSMED INC | N/A | 28.77B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.04B | ||
| NTRA | NATERA INC | N/A | 23.09B | ||
| BIIB | BIOGEN INC | 8.26 | 19.38B |
Related stock screener links
About PTHS
Company Profile
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. The company is headquartered in Durham, North Carolina and currently employs 4 full-time employees. The company went IPO on 2024-02-16. The firm's lead product, ZELSUVMI (berdazimer) topical gel, 10.3%, is used in the treatment of molluscum contagiosum infections (molluscum) in adults and pediatric patients one year of age and older. ZELSUVMI is an FDA-designated novel drug, and a prescription medication approved for the treatment of molluscum that can be administered at home by parents, patients, and caregivers. The firm is also evaluating the path forward for its existing NaV 1.7 development programs for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks.
Company Info
PELTHOS THERAPEUTICS INC
4020 Stirrup Creek Drive, Suite 110
Durham NORTH CAROLINA US
Employees: 4
Phone: 19199082422
PELTHOS THERAPEUTICS INC / PTHS FAQ
What is the stock price of PELTHOS THERAPEUTICS INC today?
The current stock price of PTHS is 23.6505 USD. The price increased by 2.87% in the last trading session.
What is the ticker symbol for PELTHOS THERAPEUTICS INC stock?
The exchange symbol of PELTHOS THERAPEUTICS INC is PTHS and it is listed on the NYSE Arca exchange.
On which exchange is PTHS stock listed?
PTHS stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for PELTHOS THERAPEUTICS INC stock?
7 analysts have analysed PTHS and the average price target is 61.2 USD. This implies a price increase of 158.77% is expected in the next year compared to the current price of 23.6505. Check the PELTHOS THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PELTHOS THERAPEUTICS INC worth?
PELTHOS THERAPEUTICS INC (PTHS) has a market capitalization of 71.90M USD. This makes PTHS a Micro Cap stock.
How many employees does PELTHOS THERAPEUTICS INC have?
PELTHOS THERAPEUTICS INC (PTHS) currently has 4 employees.
Should I buy PELTHOS THERAPEUTICS INC (PTHS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PTHS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PTHS, evaluating the profitability, health, valuation and growth aspects
- PELTHOS THERAPEUTICS INC (PTHS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PELTHOS THERAPEUTICS INC (PTHS) Sales and EPS estimates to see what analysts future expectations are.
- PELTHOS THERAPEUTICS INC (PTHS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PELTHOS THERAPEUTICS INC (PTHS) Insider and Institutional Ownership to learn about the owners and their transactions.
- PELTHOS THERAPEUTICS INC (PTHS) Stock Chart to make your own analysis
- PELTHOS THERAPEUTICS INC (PTHS) Latest news and press-releases to stay up to date.
Does PELTHOS THERAPEUTICS INC (PTHS) stock pay dividends?
PTHS does not pay a dividend.
What is the Price/Earnings (PE) ratio of PELTHOS THERAPEUTICS INC (PTHS)?
PELTHOS THERAPEUTICS INC (PTHS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-12.08).
What is the Short Interest ratio of PELTHOS THERAPEUTICS INC (PTHS) stock?
The outstanding short interest for PELTHOS THERAPEUTICS INC (PTHS) is 0.46% of its float. Check the ownership tab for more information on the PTHS short interest.
PTHS Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to PTHS.
PTHS Financial Highlights
Over the last trailing twelve months PTHS reported a non-GAAP Earnings per Share(EPS) of -12.08. The EPS decreased by -2876.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1098.3% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
PTHS Forecast & Estimates
7 analysts have analysed PTHS and the average price target is 61.2 USD. This implies a price increase of 158.77% is expected in the next year compared to the current price of 23.6505.